Cancer incidence and mortality among patients with new-onset atrial fibrillation: A population-based matched cohort study
There is a large short-term increase in cancer incidence and mortality following new-onset AF. The findings may reflect incidental identification of AF or paraneoplastic manifestation. New-onset AF confers high short-term risk of cancer diagnosis, at levels comparable with symptomatic risk threshold mandating urgent assessment for suspected cancer.
Authors
- Amand F. Schmidt (ORCID: https://orcid.org/0000-0003-1327-0424)
- Matthew Barclay (ORCID: https://orcid.org/0000-0003-1148-1922)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Georgios Lyratzopoulos (ORCID: https://orcid.org/0000-0002-2873-7421)
- Rui Providência (ORCID: https://orcid.org/0000-0001-9141-9883)
- Arturo González-Izquierdo (ORCID: https://orcid.org/0000-0002-0984-5830)
- Nadine Zakkak (ORCID: https://orcid.org/0000-0003-4155-7756)
Institutions
- St Bartholomew's Hospital (GB)
- University of Liverpool (GB)
- Cancer Research UK (GB)
- British Heart Foundation (GB)
- Liverpool Heart and Chest Hospital (GB)
- Health Data Research UK (GB)
- University College London (GB)
Publication Details
- Journal
- Neoplasia
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1016/j.neo.2024.101080
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Oregon Health and Science University
- Health and Care Research Wales
- Scottish Government
- UK Research and Innovation
- Cancer Research UK
- National Institute for Health and Care Research
- British Heart Foundation
- University College London
- Public Health Agency
- Chief Scientist Office, Scottish Government Health and Social Care Directorate
- Knight Cancer Institute, Oregon Health and Science University
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Economic and Social Research Council
- Health and Social Care Research and Development Division